Research Article Noninvasive pre-natal diagnosis of sex by maternal cell-free plasma fetal DNA analysis

Boggian, Flávia Cristina Teixeira Silva; Pinto, Ana Marta; Silvestre, Maria Asuncion A.; Jaime, J.C.; Silva, K.S.F. e; Silva, C.T. X.

doi:10.4238/gmr18559

Cited by 1 publication

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This results comes in contrary with the scientific literature that reports higher sensitivity in early pregnancy (87.5–99.1%) and it increases as the pregnancy progress (97–100%). 20 , 22 This is due to the use of less volume of sample. Present study used only <1 mL of plasma or serum is being used to extract cffDNA due to the less availability of blood samples.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Fetal Nucleated Red Blood Cells Preferable Than Cell-Free Fetal DNA for Early Determination of Gender Among Invasive and Non-Invasive Source Using Novel Four Genes Multiplex PCR

Alhur¹,

Qahtani²,

AlSuhaibani³

et al. 2021

IJGM

View full text Add to dashboard Cite

Background Deoxyribonucleic acid from invasive, non-invasive and 9th week embryo can be a resource for the determination of fetal sex using highly sensitive and specific multiplex PCR. Methods A total of 402 DNA samples were used to test the newly developed novel multiplex PCR including male specific (3 genes: SRY, DAZ2 and TSPY1 ) Y-biomarkers and internal control, ACTB . The study isolated cffDNA (Cell-free fetal DNA; n = 73) from mother’s plasma, serum and urine, fetal DNA from 9th week embryo and cord blood, and fetal DNA from CD71 +ve nucleated red blood cells (fNRBC; n = 73). Paternal and maternal DNA from buccal cells (n = 20) and blood (n = 232) used for male and female confirmation. Results The study observed that SRY alone cannot be a suitable Y-biomarker. Confirmation from any two Y-biomarkers is mandatory for male fetus identification. Direct sequencing of the gel eluted multiplex and single amplicons confirmed the specific sequences. Presence of two out of 3 Y-biomarkers OR single Y-biomarker with >1,000,000 intensity is considered positive for male. The multiplex PCR is suitable for determining sex from all source of fetal DNA including highly degraded cffDNA and can detect the sex using 0.5ng DNA. Individual marker-based real-time qPCR followed by combined melt curve analysis showed distinguished melt curve peaks for the markers. Conclusion The multiplex PCR achieved 100% accuracy on fetal DNA from fNRBC for early determinations (<13 weeks) of gender. The developed novel and simple multiplex PCR and individual qPCR can be adopted in all types of laboratories for determining human fetal gender using fetal DNA from fNRBC. Early identification of gender can support to prepare for possible X-linked analysis, reduce anxiety in mother, strengthen a bond between mother and fetus, and effective decision making. Non-invasive source of fetal DNA from fNRBC preferred for identifying gender to reduce the risk of invasive procedures in early (8–13 weeks) pregnancy.

show abstract

Section: Discussionmentioning

confidence: 99%

“…The developed single tube multiplex PCR in the study is more cost effective. The use of SRY, TSPY1 and DAZ are well studied [19][20][21] and showed high sensitivity for fetal gender determination, mostly through Real-Time PCR. However, good concentration of DNA was needed.…”

Section: Discussionmentioning

confidence: 99%